Perceived Failure of Acetaminophen and NSAIDs in Migraine: A Narrative Review of Medication Overuse, Chronification, and Pharmacogenomic Evidence
Ritisha Mukerjee
21/11/26
A perceived loss of analgesic effectiveness does not necessarily indicate true pharmacological tolerance. It may instead reflect medication overuse, migraine chronification and altered pain processing or psychological factors, which have different mechanisms and clinical implications. This review aims to distinguish perceived analgesic tolerance from true tolerance, MOH, and migraine chronification, while examining variability in analgesic response. It is focused on acetaminophen or paracetamol and NSAIDs, particularly UGT, SULT and CYP pathways involved in metabolism. PubMed- indexed literature was analysed which included clinical, neuroimaging, pharmacological, pharmacogenomic and guideline evidence. Studies addressing MOH, migraine chronification, pain processing, analgesic metabolism and genetic variation were taken into consideration. The evidence indicated that perceived analgesic failure cannot directly be attributed to tolerance. Medication overuse and migraine chronification are linked to altered pain processing and brain connectivity, while variation in UGT, SULT and CYP can influence acetaminophen metabolism and CYP2C9 variation affects selected NSAIDs. Perceived analgesic failure should not automatically be considered as pharmacological tolerance. Pharmacogenomics may explain some variation in analgesic metabolism, but evidence remains insufficient for routine personalised therapy. Unsupervised dose escalation should therefore be avoided, particularly when headaches become increasingly frequent.
